ALG 005398
Alternative Names: ALG-005398Latest Information Update: 29 May 2025
At a glance
- Originator Aligos Therapeutics
- Class Antivirals; Small molecules
- Mechanism of Action Capsid protein modulators; Hepatitis B surface antigen expression inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B